genetherapy
How one company seeks to provide hope to cancer patients through more effective treatments. Q4 2021 hedge fund letters, conferences and more Cancer is one of the most complex and difficult to treat diseases, and in 2020, it was estimated that more than 1.8 million new cases of cancer would be diagnosed in the U.S. alone and more than 600,000 patients would die from the disease. As a result, the search for effective cancer treatments remains one of the top priorities in the scientific and medical communities. Although gene therapy has been enjoying multiple successes in rare diseases, to date s...
ValueWalk
How one company seeks to provide hope to cancer patients through more effective treatments.Cancer is one of the most complex and difficult to treat diseases, and in 2020, it was estimated that more than 1.8 million new cases of cancer would be diagnosed in the U.S. alone and more than 600,000 patients would die from the disease. As a result, the search for effective cancer treatments remains one of the top priorities in the scientific and medical communities. Although gene therapy has been enjoying multiple successes in rare diseases, to date success of gene therapy in large patient population...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら